Yuan Chunchun, Yu Xiang-Tian, Wang Jing, Shu Bing, Wang Xiao-Yun, Huang Chen, Lv Xia, Peng Qian-Qian, Qi Wen-Hao, Zhang Jing, Zheng Yan, Wang Si-Jia, Liang Qian-Qian, Shi Qi, Li Ting, Huang He, Mei Zhen-Dong, Zhang Hai-Tao, Xu Hong-Bin, Cui Jiarui, Wang Hongyu, Zhang Hong, Shi Bin-Hao, Sun Pan, Zhang Hui, Ma Zhao-Long, Feng Yuan, Chen Luonan, Zeng Tao, Tang De-Zhi, Wang Yong-Jun
Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education, Shanghai, China.
Cell Discov. 2024 Mar 12;10(1):28. doi: 10.1038/s41421-024-00652-5.
Due to a rapidly aging global population, osteoporosis and the associated risk of bone fractures have become a wide-spread public health problem. However, osteoporosis is very heterogeneous, and the existing standard diagnostic measure is not sufficient to accurately identify all patients at risk of osteoporotic fractures and to guide therapy. Here, we constructed the first prospective multi-omics atlas of the largest osteoporosis cohort to date (longitudinal data from 366 participants at three time points), and also implemented an explainable data-intensive analysis framework (DLSF: Deep Latent Space Fusion) for an omnigenic model based on a multi-modal approach that can capture the multi-modal molecular signatures (M3S) as explicit functional representations of hidden genotypes. Accordingly, through DLSF, we identified two subtypes of the osteoporosis population in Chinese individuals with corresponding molecular phenotypes, i.e., clinical intervention relevant subtypes (CISs), in which bone mineral density benefits response to calcium supplements in 2-year follow-up samples. Many snpGenes associated with these molecular phenotypes reveal diverse candidate biological mechanisms underlying osteoporosis, with xQTL preferences of osteoporosis and its subtypes indicating an omnigenic effect on different biological domains. Finally, these two subtypes were found to have different relevance to prior fracture and different fracture risk according to 4-year follow-up data. Thus, in clinical application, M3S could help us further develop improved diagnostic and treatment strategies for osteoporosis and identify a new composite index for fracture prediction, which were remarkably validated in an independent cohort (166 participants).
由于全球人口迅速老龄化,骨质疏松症及相关骨折风险已成为一个广泛存在的公共卫生问题。然而,骨质疏松症具有很大的异质性,现有的标准诊断方法不足以准确识别所有有骨质疏松性骨折风险的患者并指导治疗。在此,我们构建了迄今为止最大的骨质疏松症队列的首个前瞻性多组学图谱(来自366名参与者在三个时间点的纵向数据),并基于多模态方法为全基因模型实施了一个可解释的数据密集型分析框架(DLSF:深度潜在空间融合),该方法能够捕获多模态分子特征(M3S)作为隐藏基因型的明确功能表示。据此,通过DLSF,我们在中国个体中识别出骨质疏松症人群的两种亚型及其相应的分子表型,即临床干预相关亚型(CISs),在2年随访样本中骨密度对补钙有反应。许多与这些分子表型相关的单核苷酸多态性基因揭示了骨质疏松症潜在的多种候选生物学机制,骨质疏松症及其亚型的表达数量性状位点偏好表明对不同生物学领域存在全基因效应。最后,根据4年随访数据发现这两种亚型与既往骨折的相关性不同且骨折风险也不同。因此,在临床应用中,M3S可以帮助我们进一步制定改进的骨质疏松症诊断和治疗策略,并识别一种新的骨折预测复合指标,这在一个独立队列(166名参与者)中得到了显著验证。